Correction to: Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis

Blanche P. Alter,Ana F. Best

DOI: https://doi.org/10.1007/s10549-020-05775-3

2020-07-08

Breast Cancer Research and Treatment

Abstract:In the original publication of the article, the first sentence in the abstract was published incorrectly.

oncology

What problem does this paper attempt to address?

Corrigendum to “from Phenotype to Gene: Detecting Disease‐specific Gene Functional Modules Via a Text‐based Human Disease Phenotype Network Construction” [FEBS Lett. 584 (2010) 3635–3643]

Shihua Zhang,Chao Wu,Xia Li,Xi Chen,Wei Jiang,Binsheng Gong,Li Jiang,Yuqing Yan

DOI: https://doi.org/10.1016/j.febslet.2012.12.013

2012-01-01

FEBS Letters

Abstract:The name of the first author was misspelled. The correct name should read: Shihua Zhang.
Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis

Blanche P. Alter,Ana F. Best

DOI: https://doi.org/10.1007/s10549-020-05710-6

2020-06-02

Breast Cancer Research and Treatment

Abstract:Germline pathogenic variants in BRCA1 (FANCD1) and BRCA2 (FANCS) do not explain all familial or sporadic cases with breast cancer. Several reports indicate a role for pathogenic variants in other genes in the Fanconi anemia/breast cancer DNA repair pathway; the strengths of these associations vary widely. Publications from 2006 through 2017 were reviewed to provide a better estimate of the role of pathogenic variants in genes in this pathway in breast cancer.

oncology
Errors in Key Points and Abstract

DOI: https://doi.org/10.1001/jamaoncol.2024.0267

IF: 33.006

2024-03-23

JAMA Oncology

Abstract:In the Original Investigation titled "Investigation of Genetic Alterations Associated With Interval Breast Cancer," 1 published online January 25, 2024, there were errors in the Key Points and In the Key Points, "health controls" now correctly reads "healthy controls." In the , the phrase "and associated with BRCA1/2 and PALB2 variants" is now the sentence "This association was primarily influenced by BRCA1/2 and PALB2 variants." This article was corrected online.

oncology
Correction To: Early Presence of Anti-Angiogenesis-related Adverse Events As a Potential Biomarker of Antitumor Efficacy in Metastatic Gastric Cancer Patients Treated with Apatinib: a Cohort Study

Xinyang Liu,Shukui Qin,Zhichao Wang,Jianming Xu,Jianping Xiong,Yuxian Bai,Zhehai Wang,Yan Yang,Guoping Sun,Liwei Wang,Leizhen Zheng,Nong Xu,Ying Cheng,Weijian Guo,Hao Yu,Tianshu Liu,Pagona Lagiou,Jin Li

DOI: https://doi.org/10.1186/s13045-017-0545-5

IF: 28.5

2017-01-01

Journal of Hematology & Oncology

Abstract:The original article [1] contains two errors in Table 2
Author Correction: BHMT Polymorphism and Susceptibility to PTE in Chinese Patients.

W-H Zhang,S-M Zhao,J-F Guo,Y-P Liu,Y-Q Jiang

DOI: https://doi.org/10.26355/eurrev_202307_32944

2023-01-01

European review for medical and pharmacological sciences

Abstract:Correction to: Eur Rev Med Pharmacol Sci 2023; 27 (9): 4098-4102. DOI: 10.26355/eurrev_202305_32317-PMID: 37203835-published online on May 15, 2023. After publication, the authors applied a correction in the Funding section. The section has been amended as follows: This study was supported by the research program of Jilin Provincial Science and Technology Department (No. 20190201011J). There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/32317.
Erratum: Reina-Castillón J, Pujol R, López-Sánchez M, et al. Detectable clonal mosaicism in blood as a biomarker of cancer risk in Fanconi anemia. Blood Adv. 2017;1(5):319-329

DOI: https://doi.org/10.1182/bloodadvances.2017010421

2017-07-31

Abstract:[This corrects the article DOI: 10.1182/bloodadvances.2016000943.].
Correction: A homozygous FANCM frameshift pathogenic variant causes male infertility.

Hao Yin,Hui Ma,Sajjad Hussain,Huan Zhang,Xuefeng Xie,Long Jiang,Xiaohua Jiang,Furhan Iqbal,Ihtisham Bukhari,Hanwei Jiang,Asim Ali,Liangwen Zhong,Tao Li,Suixing Fan,Beibei Zhang,Jianing Gao,Yang Li,Jabeen Nazish,Teka Khan,Manan Khan,Muhammad Zubair,Qiaomei Hao,Hui Fang,Jun Huang,Mahmoud Huleihel,Jiahao Sha,Tej K Pandita,Yuanwei Zhang,Qinghua Shi

DOI: https://doi.org/10.1038/s41436-018-0127-0

2019-01-01

Abstract:Hao Win, Hui Ma and Sajjad Hussain were incorrectly affiliated to 'Department of Radiation Oncology, The Houston Methodist Research Institute, Houston, TX 77030 USA'. These authors should only have been affiliated to 'Hefei National Laboratory for Physical Sciences at Microscale, The First Affiliated Hospital of USTC, USTC-SJH Joint Center for Human Reproduction and Genetics, The CAS Key Laboratory of Innate Immunity and Chronic Diseases, School of Life Sciences, CAS Center for Excellence in Molecular Cell Science, Collaborative Innovation Center of Genetics and Development, University of Science and Technology of China, Hefei 230027, China'. They were also not noted as contributing equally to the paper. Both these errors have now been corrected in the PDF and HTML versions of the paper.
Erratum to: Detection of a novel mutation in exon 20 of the BRCA1 gene

Abhijit Chakraborty,Atul Katarkar,Keya Chaudhuri,Ashis Mukhopadhyay,Jayasri Basak

DOI: https://doi.org/10.2478/s11658-014-0184-6

2014-03-15

Abstract:[This corrects the article DOI: 10.2478/s11658-013-0110-3.].
Correction: FGFR1β is a Driver Isoform of FGFR1 Alternative Splicing in Breast Cancer Cells

Ming Zhao,Ming-Lei Zhuo,Xiaofeng Zheng,Xiaoping Su,Funda Meric‐Bernstam

DOI: https://doi.org/10.18632/oncotarget.27353

2019-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.26530.].
Discrepancies in Genetic Testing Procedures of BRCA1/2 Mutations: A National Survey Across China (vol 24, pg 715, 2020)

Huanwen Wu,Binghe Xu,Qinglei Gao,Xiaoyan Zhou,Jianyong Shao,Zhiyong Liang,Ding Ma

DOI: https://doi.org/10.1007/s40291-021-00512-y

2021-01-01

Molecular Diagnosis & Therapy

Abstract:In the original publication of the article, text in Table 1 has a few errors as mentioned below.
Correction: Corrigendum: Identification of novel PKD1 and PKD2 mutations in a Chinese population with autosomal dominant polycystic kidney disease

Liu, Bei,Chen, Song-Chang,Yang, Yan-Mei,Yan, Kai,Qian, Ye-Qing,Zhang, Jun-Yu,Hu, Yu-Ting,Dong, Min-Yue,Jin, Fan,Huang, He-Feng,Xu, Chen-Ming

DOI: https://doi.org/10.1038/srep21578

IF: 4.6

2016-01-01

Scientific Reports

Abstract:Scientific Reports 5: Article number: 17468; published online: 03 December 2015; updated: 23 February 2016 This Article contains typographical errors in Table 2. For Family No. 19, the cDNA change ‘c.8795_8796insA’ and protein change ‘p.His2932GlnfsX5’ were incorrectly given as ‘c.8495-8496insA’ and‘p.
Correction to: Efficacy and Safety of Supportive Care Biosimilars Among Cancer Patients: A Systematic Review and Meta‑Analysis

Jichun Yang,Shuqing Yu,Zhirong Yang,Yusong Yan,Yao Chen,Hongmei Zeng,Fei Ma,Yanxia Shi,Yehui Shi,Zilu Zhang,Feng Sun

DOI: https://doi.org/10.1007/s40259-019-00378-x

IF: 7.744

2019-01-01

BioDrugs

Abstract:The authors unintentionally included in the meta-analysis both the initial abstract and the final paper of the study by Puertolas et al. [45, 48]. In order to remove this duplication, the following corrections are required.
Corrigendum to "optimization and Corroboration of the Regulatory Pathway of P42.3 Protein in the Pathogenesis of Gastric Carcinoma".

Yibin Hao,Tianli Fan,Kejun Nan

DOI: https://doi.org/10.1155/2015/606043

IF: 2.809

2015-01-01

Computational and Mathematical Methods in Medicine

Abstract:In the article “Optimization and Corroboration of the Regulatory Pathway of p42.3 Protein in the Pathogenesis of Gastric Carcinoma” [1], there was an error in the author information. The affiliations for the authors were incorrectly listed. The correct author line and affiliations are shown above.
Publisher Correction: Homologous Recombination DNA Repair Defects in PALB2-associated Breast Cancers

An‐Qi Li,Felipe C. Geyer,Pedro Blecua,Ju Youn Lee,Pier Selenica,David Brown,Fresia Pareja,Simon S. K. Lee,Rahul Kumar,Bárbara Rivera,Rui Bi,Salvatore Piscuoglio,Hannah Y. Wen,John R. Lozada,Rodrigo Gularte‐Mérida,Luca Cavallone,Morteza Aghmesheh,David J. Amor,Leslie R. Andrews,Yoland Antill,Rosemary L. Balleine,Roger L. Milne,Anneke C. Blackburn,Michael Bogwitz,Melissa A. Brown,Matthew Burgess,Jo Burke,Phyllis Butow,Liz Caldon,Ian Campbell,Alice Christian,Christine L. Clarke,Paul Cohen,Ashley Crook,James Cui,Margaret C. Cummings,Sarah‐Jane Dawson,Anna deFazio,Martin B. Delatycki,Alexander Dobrovic,Tracy Dudding,Pascal H. G. Duijf,Edward Edkins,Stacey L. Edwards,Gelareh Farshid,Andrew Fellows,Michael Field,James M. Flanagan,Peter C.C. Fong,John Forbes,Laura Forrest,Stephen B. Fox,Juliet D. French,Michael Friedlander,David Gallego‐Ortega,Michael Gattas,Graham G. Giles,Grantley Gill,Margaret Gleeson,Sian Greening,Eric Haan,Marion Harris,Nicholas K. Hayward,Ian B. Hickie,John L. Hopper,Clare Hunt,Paul A. James,Mark A. Jenkins,Richard Kefford,Maira Kentwell,Judy Kirk,James Kollias,Sunil R. Lakhani,Geoffrey J. Lindeman,Lara Lipton,Lizz Lobb,Sheau Wen Lok,Finlay Macrea,Graham J. Mann,Debbie J. Marsh,Sue‐Anne McLachlan,Bettina Meiser,Sophie Nightingale,Shona O’Connell,Nick Pachter,Briony Patterson,Kelly‐Anne Phillips,Mona Saleh,Elizabeth Salisbury,Christobel Saunders,Jodi M. Saunus,Clare L. Scott,Rodney J. Scott,Adrienne Sexton,Andrew N. Shelling,Peter T. Simpson,Allan D. Spigelman,Mandy Spurdle,Jennifer Stone,Jessica Taylor,Heather Thorne,Alison H. Trainer,Georgia Chenevix‐Trench,Kathy Tucker,Jane E. Visvader,Logan C. Walker,Mathew Wallis,Rachael Williams,Ingrid Winship,Kathy Wu,Mary‐Anne Young,Zoulikha Rezoug,Tu Nguyen‐Dumont,Paolo Peterlongo,Carlo Tondini,Thorkild Terkelsen,Karina Rønlund,Susanne E. Boonen,Robert Winqvist,Markéta Janatová,Pathmanathan Rajadurai,Bing Xia,Larry Norton,Mark E. Robson,Pei-Sze Ng,Lai‐Meng Looi,Melissa C. Southey,Britta Weigelt,Soo‐Hwang Teo,Marc Tischkowitz,William D. Foulkes,Jorge S. Reis‐Filho

DOI: https://doi.org/10.1038/s41523-019-0140-8

2019-01-01

npj Breast Cancer

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Correction To: Proteogenomic Characterization and Comprehensive Integrative Genomic Analysis of Human Colorectal Cancer Liver Metastasis

Yu‐Shui Ma,Tao Huang,Xiaoming Zhong,Hongwei Zhang,Xianling Cong,Hong Xu,Gai‐Xia Lu,Fei Yu,Sheng Xue,Zhongwei Lv,Da Fu

DOI: https://doi.org/10.1186/s12943-019-1005-3

IF: 37.3

2019-01-01

Molecular Cancer

Abstract:Following publication of the original article [1], the authors reported an error in affiliation 5.
Publisher Correction: Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy

Jennifer L. Caswell-Jin,Katherine McNamara,Johannes G. Reiter,Ruping Sun,Zheng Hu,Zhicheng Ma,Jie Ding,Carlos J. Suarez,Susanne Tilk,Akshara Raghavendra,Victoria Forte,Suet-Feung Chin,Helen Bardwell,Elena Provenzano,Carlos Caldas,Julie Lang,Robert West,Debu Tripathy,Michael F. Press,Christina Curtis

DOI: https://doi.org/10.1038/s41467-019-10456-x

IF: 16.6

2019-01-01

Nature Communications

Abstract:The original version of this Article omitted from the Author Contributions statement that ‘R.S. and J.G.R contributed equally to this work.’ This has been corrected in both the PDF and HTML versions of the Article.
ERRATUM: Mutational landscape of non-functional adrenocortical adenomas

Luming Wu,Jing Xie,Yan Qi,Tingwei Su,Lei Jiang,Weiwei Zhou,Yiran Jiang,Cui Zhang,Xu Zhong,Yanan Cao,Weiqing Wang

DOI: https://doi.org/10.1530/erc-21-0410e

2024-02-01

Endocrine Related Cancer

Abstract:The authors and journal apologise for an error in the above paper, which appeared in volume 29 part 9, pages 521–532. The error relates to Table 3 given on page 526, in which the units for Aldosterone were given as ng/dL, when the units should have been given as pg/mL. The corrected Table 3 is given in full below.

oncology,endocrinology & metabolism
Correction: the Hmlh1 −93g>a Polymorphism and Risk of Ovarian Cancer in the Chinese Population

Leilei Niu,Shumin Li,Huamao Liang,Hua Li

DOI: https://doi.org/10.1371/journal.pone.0218032

IF: 3.7

2019-01-01

PLoS ONE

Abstract:[This corrects the article DOI: 10.1371/journal.pone.0135822.].
Correction: Smith et al. MCAK Inhibitors Induce Aneuploidy in Triple-Negative Breast Cancer Models. Cancers 2023, 15, 3309

John C. Smith,Stefan Husted,Jay Pilrose,Stephanie C. Ems-McClung,Jane R. Stout,Richard L. Carpenter,Claire E. Walczak

DOI: https://doi.org/10.3390/cancers16020293

2024-01-11

Cancers

Abstract:The authors alerted the Editorial Office of the mistake on 5 August 2023 and the final documents were sent for evaluation on 12 December 2023 [...]

oncology
Erratum: Extensive patient-to-patient single nucleus transcriptome heterogeneity in pheochromocytomas and paragangliomas

Frontiers Production Office

DOI: https://doi.org/10.3389/fonc.2024.1469606

2024-08-01

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.965168.].

Correction to: Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis

Corrigendum to “from Phenotype to Gene: Detecting Disease‐specific Gene Functional Modules Via a Text‐based Human Disease Phenotype Network Construction” [FEBS Lett. 584 (2010) 3635–3643]

Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis

Errors in Key Points and Abstract

Correction To: Early Presence of Anti-Angiogenesis-related Adverse Events As a Potential Biomarker of Antitumor Efficacy in Metastatic Gastric Cancer Patients Treated with Apatinib: a Cohort Study

Author Correction: BHMT Polymorphism and Susceptibility to PTE in Chinese Patients.

Erratum: Reina-Castillón J, Pujol R, López-Sánchez M, et al. Detectable clonal mosaicism in blood as a biomarker of cancer risk in Fanconi anemia. Blood Adv. 2017;1(5):319-329

Correction: A homozygous FANCM frameshift pathogenic variant causes male infertility.

Erratum to: Detection of a novel mutation in exon 20 of the BRCA1 gene

Correction: FGFR1β is a Driver Isoform of FGFR1 Alternative Splicing in Breast Cancer Cells

Discrepancies in Genetic Testing Procedures of <i>BRCA1/2</i> Mutations: A National Survey Across China (vol 24, pg 715, 2020)

Correction: Corrigendum: Identification of novel PKD1 and PKD2 mutations in a Chinese population with autosomal dominant polycystic kidney disease

Correction to: Efficacy and Safety of Supportive Care Biosimilars Among Cancer Patients: A Systematic Review and Meta‑Analysis

Corrigendum to "optimization and Corroboration of the Regulatory Pathway of P42.3 Protein in the Pathogenesis of Gastric Carcinoma".

Publisher Correction: Homologous Recombination DNA Repair Defects in PALB2-associated Breast Cancers

Correction To: Proteogenomic Characterization and Comprehensive Integrative Genomic Analysis of Human Colorectal Cancer Liver Metastasis

Publisher Correction: Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy

ERRATUM: Mutational landscape of non-functional adrenocortical adenomas

Correction: the Hmlh1 −93g&gt;a Polymorphism and Risk of Ovarian Cancer in the Chinese Population

Correction: Smith et al. MCAK Inhibitors Induce Aneuploidy in Triple-Negative Breast Cancer Models. Cancers 2023, 15, 3309

Erratum: Extensive patient-to-patient single nucleus transcriptome heterogeneity in pheochromocytomas and paragangliomas

Correction: the Hmlh1 −93g>a Polymorphism and Risk of Ovarian Cancer in the Chinese Population